絞り込み

16640

広告

Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.

著者 Mantovani LG , Haas S , Kreutz R , Folkerts K , Gebel M , Monje D , Schneider J , van Eickels M , Sahin K , Zell E , Ageno W , Turpie AGG
Eur J Intern Med.2018 Oct 18 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (138view , 0users)

Full Text Sources

Medical

The non-interventional XALIA study compared the safety and effectiveness of rivaroxaban with standard anticoagulation for the treatment of venous thromboembolism in routine clinical practice. This substudy assessed the effect of treatment with rivaroxaban on healthcare resource use, hospital length of stay (LOS) and frequency of hospitalisation.
PMID: 30342973 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード